0001836716-20-000001.txt : 20201216 0001836716-20-000001.hdr.sgml : 20201216 20201216104315 ACCESSION NUMBER: 0001836716-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201216 DATE AS OF CHANGE: 20201216 EFFECTIVENESS DATE: 20201216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VIN-21 Nob Hill Therapeutics, LLC CENTRAL INDEX KEY: 0001836716 IRS NUMBER: 853636756 STATE OF INCORPORATION: AR FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-383352 FILM NUMBER: 201391524 BUSINESS ADDRESS: STREET 1: 535 W. RESEARCH CENTER BLVD. STREET 2: SUITE 135 CITY: FAYETTEVILLE STATE: AR ZIP: 72701 BUSINESS PHONE: 4795212592 MAIL ADDRESS: STREET 1: 535 W. RESEARCH CENTER BLVD. STREET 2: SUITE 135 CITY: FAYETTEVILLE STATE: AR ZIP: 72701 D 1 primary_doc.xml X0708 D LIVE 0001836716 VIN-21 Nob Hill Therapeutics, LLC 535 W. RESEARCH CENTER BLVD. SUITE 135 FAYETTEVILLE AR ARKANSAS 72701 4795212592 ARKANSAS None None Limited Liability Company true 2020 Robert Calvin Goforth 535 W. Research Center Blvd. Suite 135 Fayetteville AR ARKANSAS 72701 Executive Officer Director CEO of Manager. Other Decline to Disclose 06b false 2020-12-09 false true false 5000 None None None None N/A N/A Fayetteville AR ARKANSAS 72701 AR ARKANSAS NC NORTH CAROLINA TX TEXAS false 500000 60000 440000 false 10 0 0 0 false VIN-21 Nob Hill Therapeutics, LLC Robert Calvin Goforth Robert Calvin Goforth CEO of Manager 2020-12-16